Crossject - Needle-Free Device Technology

Crossject is a leader in the design and development of innovative needle-free device technology for the pharmaceutical industry.

Crossject's technology can be adapted to most injectable pharmaceuticals and vaccines, providing a multi-billion dollar commercial opportunity for both the company and its partners. Further partnering agreements, for human and animal health products including biotech and bio-similar therapeutics discussions are in progress.

Zeneo - needle-free, single-use injection device

Crossject's main product platform, Zeneo, is a needle-free, pre-filled, single-use injection device that is able to adapt to different injection depths (intradermal, subcutaneous, intramuscular) and the physical characteristics – viscosity, volume (from 0.1 to 0.6 ml) etc – of the injectable active substance.

With 800,000 injuries caused by needles every year in the US, Zeneo eliminates contamination risks by avoiding injuries. Zeneo brings simplicity to patient care while providing safety (self injection and emergency situations) and ensures accuracy of delivery. Zeneo also improves patient compliance by avoiding needle phobia. Additionally it can be filled on standard syringe filling lines.

Crossject
12 Quai Henri IV
75004 Paris
France

Tel: +33 (0)1 48 04 67 45
info@crossject.com
www.crossject.com